HealthDay News — Trajectories of emotion regulation across ages 3 to 7 years predict attention-deficit/hyperactivity disorder (ADHD) symptoms, as well as conduct problems, according to a study ...

HealthDay News — Work-time activity behavior, rather than leisure-time or non-workday, seems to be associated with 24-hour ambulatory blood pressure, according to a study published online in Medicine ...

At ObesityWeek 2024, researchers presented the latest data on treatment regimens for chronic weight management, including GLP ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

The American Academy of Sleep Medicine published guidance regarding the treatment of restless leg syndrome and periodic limb movement disorder.

After peak in 2020, significant decrease seen in firearm injury-related visit rates year over year from 2020 to 2023 ...

Researchers assessed the safety and efficacy of apremilast over a 48-week period for the treatment of early oligoarticular psoriatic arthritis.

Seasonal maternal RSV vaccination may be cost-effective, as well as nirsevimab, particularly for those with higher risks.

The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for the emergency treatment of known or suspected opioid overdose in adults an ...

Researchers evaluated the efficacy and safety of ixekizumab over a 16-week period for the treatment of juvenile psoriatic arthritis or enthesitis-related arthritis.

Sodium oxybate was significantly more effective at reducing symptoms than placebo for patients with alcohol-responsive LD but not those whose symptoms do not improve with alcohol.